Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients

Authors:
  • YZYueming Zhao
    Yueming Zhao
  • YWYuchan Wang
    Yuchan Wang
  • MLMudan Lu
    Mudan Lu
  • CCChun Cheng
    Chun Cheng
  • XHXiaodong Huang
    Xiaodong Huang
  • DZDongmei Zhang
    Dongmei Zhang
  • JLJianxin Lu
    Jianxin Lu
  • SHSong He
    Song He
  • ASAiguo Shen
    Aiguo Shen

Abstract
To investigate whether Foxo3a expression is correlated with p27(kip1) protein levels as well as how it might be clinically relevant, we evaluated the expression of Foxo3a in several ovarian tumors. Immunohistochemical analysis was performed in 63 cases of ovarian tumors. Ten cases were evaluated by Western blot analysis. There was a correlation observed between Foxo3a over-expression and clinic pathological parameters (p = 0.032). Kaplan-Meier survival analysis showed that Foxo3a low expression was significantly associated with poor prognosis of patients. It may be a useful prognostic marker and target in ovarian cancer.

This publication has 36 references indexed in Scilit: